[HTML][HTML] Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor …
T De Pas, F Toffalorio, M Manzotti, C Fumagalli… - Journal of Thoracic …, 2011 - Elsevier
Introduction Mutations of the epidermal growth factor receptor (EGFR) have been proven to
predict activity of the EGFR-tyrosine kinase inhibitors (EGFR-TKI), gefitinib and erlotinib …
predict activity of the EGFR-tyrosine kinase inhibitors (EGFR-TKI), gefitinib and erlotinib …
Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor …
T De Pas, F Toffalorio, M Manzotti, C Fumagalli… - Journal of Thoracic …, 2011 - jto.org
Introduction Mutations of the epidermal growth factor receptor (EGFR) have been proven to
predict activity of the EGFR-tyrosine kinase inhibitors (EGFR-TKI), gefitinib and erlotinib …
predict activity of the EGFR-tyrosine kinase inhibitors (EGFR-TKI), gefitinib and erlotinib …
Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor …
T De Pas, F Toffalorio, M Manzotti… - Journal of thoracic …, 2011 - pubmed.ncbi.nlm.nih.gov
Introduction Mutations of the epidermal growth factor receptor (EGFR) have been proven to
predict activity of the EGFR-tyrosine kinase inhibitors (EGFR-TKI), gefitinib and erlotinib …
predict activity of the EGFR-tyrosine kinase inhibitors (EGFR-TKI), gefitinib and erlotinib …
[PDF][PDF] Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor …
MD Tommaso De Pas, F Toffalorio, M Manzotti… - Journal of Thoracic …, 2011 - core.ac.uk
Methods: The frequency of rare mutations has been investigated in 681 cases of non-small
cell lung cancer screened between 2006 and 2010. Mutations in exons 18 and 20 …
cell lung cancer screened between 2006 and 2010. Mutations in exons 18 and 20 …
Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor …
T De Pas, F Toffalorio, M Manzotti, C Fumagalli… - JOURNAL OF …, 2011 - air.unimi.it
Mutations of the epidermal growth factor receptor (EGFR) have been proven to predict
activity of the EGFR-tyrosine kinase inhibitors (EGFR-TKI), gefitinib and erlotinib. Although …
activity of the EGFR-tyrosine kinase inhibitors (EGFR-TKI), gefitinib and erlotinib. Although …
[PDF][PDF] Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor …
MD Tommaso De Pas, F Toffalorio… - Journal of Thoracic …, 2011 - researchgate.net
Methods: The frequency of rare mutations has been investigated in 681 cases of non-small
cell lung cancer screened between 2006 and 2010. Mutations in exons 18 and 20 …
cell lung cancer screened between 2006 and 2010. Mutations in exons 18 and 20 …
[引用][C] Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor …
T De Pas, F Toffalorio, M Manzotti, C Fumagalli… - Journal of Thoracic …, 2011 - cir.nii.ac.jp
Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small
Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations | CiNii …
Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations | CiNii …
[PDF][PDF] Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor …
MD Tommaso De Pas, F Toffalorio… - Journal of Thoracic …, 2011 - scholar.archive.org
Methods: The frequency of rare mutations has been investigated in 681 cases of non-small
cell lung cancer screened between 2006 and 2010. Mutations in exons 18 and 20 …
cell lung cancer screened between 2006 and 2010. Mutations in exons 18 and 20 …
Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor …
T De Pas, F Toffalorio, M Manzotti… - Journal of Thoracic …, 2011 - europepmc.org
Methods The frequency of rare mutations has been investigated in 681 cases of non-small
cell lung cancer screened between 2006 and 2010. Mutations in exons 18 and 20 …
cell lung cancer screened between 2006 and 2010. Mutations in exons 18 and 20 …